Hereditary hemorrhagic telangiectasia (Osler's disease). An interdisciplinary challenge;Hereditäre hämorrhagische teleangiektasie (Morbus Osler). Eine interdisziplinäre herausforderung

HNO

Volumn 50, Issue 2, 2002, Pages 114-128

  Geisthoff, U W ^a   Schneider, G ^a   Fischinger, J ^a   Plinkert, P K ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Arteriovenous malformations; Epistaxis; HHT; Osler Weber Rendu disease; PAVM

Indexed keywords

ANTIFIBRINOLYTIC AGENT;

ARGON PLASMA COAGULATION; ARTERIOVENOUS MALFORMATION; ARTIFICIAL EMBOLISM; AUTOSOMAL DOMINANT DISORDER; BRACHYTHERAPY; BRAIN ARTERIOVENOUS MALFORMATION; CLINICAL FEATURE; EPISTAXIS; FAMILY HISTORY; GASTROINTESTINAL DISEASE; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; LIVER; LOW LEVEL LASER THERAPY; LUNG; QUALITY OF LIFE; RENDU OSLER WEBER DISEASE; REVIEW; SCREENING TEST; VISCERA;

EID: 0036937586     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001060100537     Document Type: Review

References (75)

1. American Heart Association (1997) Prevention of bacterial endocarditis. JAMA 277: 1794-1801
2. Babington BG (1865) Hereditary epistaxis. Lancet 2: 362-363
3. Ballauff A, Koletzko S (1999) Hereditary hemorrhagic telangiectasia with juvenile polyposis - coincidence or linked autosomal dominant inheritance? Z Gastroenterol 37: 385-388
4. Berg JN, Guttmacher AE, Marchuk DA et al. (1996) Clinical heterogenity in hereditary hemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 33: 256-257
5. Bergler W, Götte K (1999) Hereditary hemorrhagic telangiectasias: a challenge for the clinician. Eur Arch Otorhinolaryngol 256: 10-15
6. Bergler W, Riedel F, Baker-Schreyer A, Juncker C, Hörmann K (1999) Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia. Laryngoscope 109: 15-20
7. Boillot O, Bianco F, Viale JP et al. (1999) Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. Gastroenterology 116: 187-192
8. Bourdeau A, Cymerman U, Paquet ME et al. (2000) Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol 156: 911-923
9. Bourdeau A, Dumont DJ, Letarte M (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104: 1343-1351
10. Brant AM, Schachat AP, White RI (1989) Ocular manifestations in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber Disease). Am J Ophtal 107: 642-646
11. Braverman IM, Keh A, Jacobson BS (1990) Ultrastructure and three-dimensional organization of the teleangiectases of hereditary hemorrhagic teleangiectasia. J Invest Dermatol 95: 422-427
12. Byahatti SV, Rebeiz EE, Shapshay SM (1997) Hereditary hemorrhagic telangiectasia: what the otolaryngologist should know. Am J Rhinol 11: 55-62
13. Cachin Y, Sauvage JP, Schwaab G (1976) La maladie de Rendu-Osler: à propos de 50 cas suivis à l'Institut Gustave-Roussy. Ann Otol Larngol (Paris) 93: 103-108
14. Caselitz M, Wagner S, Chavan A et al. (1998) Clinical outcome of transfemoral embolisation in patients with arteriovenous malformations of the liver in hereditary haemorrhagic telangiectasia (Weber-Rendu-Osler disease). Gut 42: 123-126
15. Cutsem van E, Rutgeerts P, Vantrappen G (1990) Treatment of bleeding gastrointestinal malformations with oestrogen-progesterone. Lancet 335: 953-955
16. Cymerman U, Vera S, Pece-Barbara N, Bourdeau A, White RI, Dunn J, Letarte M (2000) Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatr Res 47: 24-35
17. Garcia-Tsao G, Korzenik JR, Young L et al. (2000) Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 28: 931-936
18. Garland HG, Anning ST (1950) Hereditary hemorrhagic telangiectasia: A genetic an bibliographic study. Br J Dermatol Syphilis 62: 289-310
19. Gluckman JL, Portugal LG (1994) Modified Young's procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia. Laryngoscope 104: 1174-1177
20. Guttmacher AE, Marchuk DA, White RI (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med 333: 918-924
21. Haitjema T, Disch F, Overtoom TT, Westermann CJ, Lammers JW (1995) Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 99: 519-524
22. Hanes FM (1909) Multiple hereditary telangiectases cause hemorrhage (hereditary hemorrhagic telangiectasia). Johns Hopkins Bull 20: 63-73
23. Hanna W, McCarroll D, Lin D et al. (1984) A study of a Caucasian family with variant von Willebrand's disease in association with vascular telangiectasia and haemoglobinopathy. Thromb Haemostas 1: 275-278
24. Harries PG, Brockbank MJ, Shakespeare PG, Carruth JAS (1997) Treatment of hereditary haemorrhagic telangiectasia by the pulsed dye laser. J Laryngol Otol 111: 1038-1041
25. Haye R, Austad J (1992) Hereditary haemorrhagic teleangiectasia: unsuccessful treatment with the flashlamp-pulsed dye laser. Rhinology 30: 135-137
26. Hosni AA, Innes AJ (1994) Hereditary hemorrhagic telangiectasia: Young's procedure in the management of epistaxis. J Laryngol Otol 108: 754-757
27. HHT Foundation International, Inc. (2000) Our most frequently asked questions. Direct Connection, Eigenverlag der HHT Foundation, New Haven, USA, March 2000
28. Johnson DW, Berg JN, Baldwin MA et al. (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nature Gen 13: 189-195
29. Kjeldsen AD (1997) Epidemiological and clinical aspect of hereditary haemorrhagic telangiectasia. Faculty of Health Sciences, Odense University, Odense, pp 33
30. Kjeldsen AD, Oxhoj H, Andersen PE, Elle B, Jacobsen JP, Vase P (1999) Pulmonary arteriovenous malformations: screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest 116: 432-439
31. Kjeldsen AD, Vase P, Oxhøj H (1996) Letter to the editor. N Engl J Med 334: 331
32. Kjeldsen AD, Vase P, Green A (1999) Hereditary hemorrhagic telangiectasia: a populationbased study of prevalence and mortality in Danish patients. J Intern Med 245: 31-39
33. Kurnik PB, Heymann WR (1989) Coronary artery extasia associated with hereditary hemorrhagic telangiectasia. Arch Intern Med 149: 2357-2359
34. Legg W (1876) A case of haemophilia complicated with multiple naevi. Lancet 2: 856
35. Lennox PA, Harries M, Lund VJ, Howard DJ (1997) A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary hemorrhagic telangiectasia. J Laryngol Otol 111: 34-37
36. Li DY, Sorensen LK, Brooke BS et al. (1999) Defective angiogenesis in mice lacking Endoglin. Science 284: 1534-1537
37. Lund VJ, Howard DJ (1997) Closure of the nasal cavities in the treatment of refractory hereditary hemorrhagic telangiectasia. J Laryngol Otol 111: 30-33
38. Mager JJ, Westermann CJ (2000) Value of capillary microscopy in the diagnosis of hereditary hemorrhagic telangiectasia. Arch Dermatol 136: 732-734
39. Marchuk DA (1998) Genetic abnormalities in hereditary hemorrhagic telangiectasia. Current Opin Hematol 5: 332-338
40. Marchuk DA, Guttmacher AE, Penner JA, Ganguly P (1998) Report on the workshop on hereditary hemorrhagic telangiectasia. Am J Med Gen 76: 269-273
41. Matsubara S, Manzia JL, ter Brugge K, Willinsky RA, Montanera W, Faughnan ME (2000) Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol 21: 1016-1020
42. McAllister KA, Grogg KM, Johnson DW et al. (1994) Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1. Nature Gen 8: 345-351
43. McDonald JE, Miller FJ, Hallam SE, Nelson L, Marchuk DA, Ward KJ (2000) Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred. Am J Med Genet 93: 320-327
44. Mirra JM, Arnold WD (1973) Skeletal Hemangiomatosis in association with hereditary hemorrhagic telangiectasia. J Bone Joint Surg 55: 850-854
45. Naveau S, Aubert A, Poynard T, Chaput JC (1990) Long-term results of treatment of vascular malformations of the gastrointestinal tract by neodymium YAG laser photocoagulation. Dig Dis Sci 35: 821-826
46. Osler W (1901) On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Johns Hopkins Hosp Bull 12: 333-337
47. Parkin, JL, Dixon JA (1981) Laser photocoagulation in hereditary hemorrhagic telangiectasia. Otolaryngol. Head Neck Surg 89: 204-208
48. Piantanida M, Buscarini E, Dellavecchia C, Minelli A, Rossi A, Buscarini L, Danesino C (1996) Hereditary hemorrhagic telangiectasia with extenxive liver involvment is not caused by either HHT1 or HHT2. J Med Gen 33: 441-443
49. Plauchu H, Bideau A (1984) Épidémiologie et constitution d'un registre de population à propos d'une concentration géographique d'une maladie héréditaire rare. Population 4: 765-786
50. Plauchu H, de Chadarevian JP, Bedeau A, Robert JM (1989) Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Ame J Med Gen 32: 291-297
51. Porteous MEM, Burn J, Proctor SJ(1992) Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Gen 29: 527-530
52. Reilly PJ, Nostrant TT (1984) Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroent 79: 363-367
53. Rendu M (1896) Épistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux. Bull Soc Méd Hôp (Paris) 13: 731-733
54. Saluja S, Henderson KJ, White RI Jr (2000) Embolotherapy in the bronchial and pulmonary circulations. Radiol Clin North Am 38: 425-448
55. Serrano E, Percodani J, Pessey JJ (1998) La fermeture bilaterale des fosses nasales. Une technique chirurgicale originale du traitement des epistaxis recidivantes graves de la maladie de Rendu-Osler. Ann Otolaryngol Chir Cervicofac 115: 169-73
56. Shapshay MS, Oliver P (1984) Treatment of hereditary hemorrhagic telangiectasia by Nd-YAG laser photocoagulation. Laryngoscope 94: 1554-1556
57. Shovlin CL (1997) Molecular defects in rare bleeding disorders: hereditary hemorrhagic telangiectasia. Thromb Haemostasis 78: 145-150
58. Shovlin CL, Guttmacher AE, Buscarini E et al. (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Gen 91: 66-67
59. Shovlin C, Hughes JMB, Scott J, Seidman E, Seidman JG (1997) Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 61: 68-79
60. Shovlin CL, Letarte M (1999) Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 54: 714-29
61. Shovlin CL, Winstock AR, Peters AM, Jackson JE, Hughes JMB (1995) Medical complications of pregnancy in hereditary hemorrhagic telangiectasia. Quart J Med 88: 879-887
62. Snyder LH, Doan CA (1944) Clinical and experimental. Studies in human inheritance. Is the homozygous form of multiple telangiectasia lethal? J Lab Clin Med 29: 1211-1216
63. Spies T, Stinner B, Guercio M, Rothmund M (1996) Interventionelle Endoskopie mit dem Argon-Plasma-Koagulator: Erfahrungen in der Allgemeinchirurgie. Langenbecks Arch Chir Kongressbd 113 [Suppl]: 537-539
64. Suresh CG, Coupe MO, Jegarajah S (1995) Recurrent cerebral abscesses 20 years before recognition of multiple pulmonary arteriovenous malformations. Br J Clin Pract 49: 105-106
65. Sutton HG (1864) Epistaxis as an indication of impaired nutrition, and of degeneration of the vascular system. Medical Mirror 1: 769-781
66. Berg JW, Dippel DW, Habbema JD, Westermann CJ, Tulleken CA, Willemse J (1993) Unruptured intracranial arteriovenous malformations with hereditary haemorrhagic telangiectasia. Neurosurgical treatment or not? Acta Neurochir (Wien) 121: 34-42
67. Turjman F, Massoud TF, Vinuela F, Sayre JW, Guglielmi G, Duckwiler G (1995) Correlation of the angioarchitectural features of cerebral arteriovenous malformations with clinical presentation of hemorrhage. Neurosurgery 37: 856-860
68. Ueda M, Abe Y, Fujiwara H et al. (1993) Prominent telangiectasia associated with marked bleeding in CREST syndrome. J Dermatol 20: 180-184
69. Wallace GM, Shovlin CL (2000) A hereditary hemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Thorax 55: 685-690
70. Weber FP (1907) Multiple hereditary developmental angiomata (teleangiectases) of the skin and mucous membranes associated with recurring haemorrhages. Lancet 2: 160-162
71. Werner JA, Geisthoff UW, Lippert BM, Rudert H (1997) Behandlung der rezidivierenden Epistaxis beim Morbus Rendu-Osler-Weber. HNO 45: 673-681
72. White RI Jr (1992) Pulmonary arteriovenous malformations: how to diagnose them and why is it important to do so? Radiology 182: 633-635
73. White RI Jr (1995) Screening for families with HHT. HHT Foundation International, New Haven, USA
74. White RI Jr, Lynch-Nyhan A, Terry P et al. (1988) Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 169: 663-669
75. Willinsky RA, Lasjaunias P, Terbrugge K, Burrows P (1990) Multiple cerebral arteriovenous malformations (AVMs). Review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology 32: 207-10